Atypical hemolytic uremic syndrome due to factor H autoantibody

Turkish Journal of Pediatrics

Volumn 55, Issue 1, 2013, Pages 86-89

  Uslu Gökceoǧlu, Arife ^a   Doǧan, Çagla Serpil ^a   Çomak, Elif ^a   Koyun, Mustafa ^a   Akman, Sema ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Atypical hemolytic uremic syndrome; Autoantibody; Complement; Complement factor H; Complement factor H related protein

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H ANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYSTATIN; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMA PROTEIN; PREDNISOLONE; PROTEIN CFHR 1; PROTEIN CFHR 3; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANEMIA; ANTIBODY TITER; ARTICLE; BRAIN DISEASE; CASE REPORT; CHILD; COMPLEMENT BLOOD LEVEL; CONVULSION; CREATININE BLOOD LEVEL; DEFICIENCY OF CFHR PROTEIN AND CFH AUTOANTIBODY POSITIVE HEMOLYTIC UREMIC SYNDROME; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; GLOMERULUS FILTRATION RATE; HEMATURIA; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HEPATOMEGALY; HUMAN; HYPERVOLEMIA; KIDNEY FAILURE; LEUKOPENIA; MALAISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; PLASMAPHERESIS; PROTEINURIA; SCHOOL CHILD; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; UREMIA; VOMITING;

AUTOANTIBODIES; BLOOD PROTEINS; CHILD; COMPLEMENT C3B INACTIVATOR PROTEINS; COMPLEMENT FACTOR H; CREATININE; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY DISEASES;

EID: 84876574033     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Loirat C, Noris M, Bacchi VF. Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2008; 23: 1957-1972.
2. Besbas N, Karpman D, Landau D, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytic purpura and related disorders. Kidney Int 2006; 70: 423-431.
3. Zipfel P, Mache C, Müler D, et al. European DEAP-HUS Study Group. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol 2010; 25: 2009-2019.
4. Noris M, Remuzzi G. Atypical hemolytic uremic syndrome. N Engl J Med 2009; 361: 1676-1687.
5. Ariceta G, Besbas N, Johnson S, et al. European Paediatric Research Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009; 24: 687-696.
6. Jozsi M, Licht C, Strobel S, et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood 2008; 111: 1512-1514.
7. Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol 2010; 25: 2431-2442.
8. Corral PS, Melgosa M. Advances in understanding the etiology of atypical hemolytic uremic syndrome. Br J Haematol 2010; 150: 529-542.
9. Boye O, Balzamo E, Charbit M, et al. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anticomplement factor H autoantibodies. Am J Kidney Dis 2010; 55: 923-927.